Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Private company

Castle Creek Biosciences, Inc.

Biotechnology
Headquarters—
Founded—
Last known round—
Reported valuation—

Security-class differences are disclosed on the affected rows; non-degenerate marks remain in the underlying-company comparison band. 3 rows are omitted from dispersion statistics under the degenerate-mark guard; each affected row states why.

Cross-fund comparison

Equity & warrant marks

One underlying-company band; one latest disclosed mark per fund and security.

FundFair valueSecurity / annotationsImplied price / shareMark age vs roundMethodology / filing
HRZNHorizon Technology Finance Corp$217KMar 31, 2026 · source ↗equityFair ValueNo valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.Likely warrant coverage attached to credit facility — MELD classification judgment.Omitted from statistics — Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.$186.75Mar 31, 2026 · source ↗—Mar 31, 2026 · source ↗10-Q 2026-03-31 ↗
HRZNHorizon Technology Finance Corp$177KMar 31, 2026 · source ↗warrantFair ValueFiled as warrant; the comparison band's majority class is equity.No valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.Likely warrant coverage attached to credit facility — MELD classification judgment.Omitted from statistics — Carried at warrant/option value (net of strike), not underlying share value — not comparable to share marks as filed.$12.81Mar 31, 2026 · source ↗—Mar 31, 2026 · source ↗10-Q 2026-03-31 ↗

Cross-fund comparison

Debt investments

Included in the same underlying-company comparison band.

FundSecurity type / annotationsPrincipalFair valueFV / principalRateMaturityMark age vs roundNon-accrual
HRZNHorizon Technology Finance Corpsenior secured loanFair Value — Term LoanFiled as senior secured loan; the comparison band's majority class is equity.No valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Omitted from statistics — security type is not an eligible fund-equity mark for dispersion.$5MMar 31, 2026 · source ↗$5MMar 31, 2026 · source ↗99.5%Mar 31, 2026 · source ↗Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 4.00%Mar 31, 2026 · source ↗Mar 1, 2028Mar 31, 2026 · source ↗—Mar 31, 2026 · source ↗NoMar 31, 2026 · source ↗

Historical marks

Reported fair value by fund

Each bar is a disclosed position-quarter.

$177KHRZNMar 31, 2026 · source ↗$217KHRZNMar 31, 2026 · source ↗$5MHRZNMar 31, 2026 · source ↗$10MHRZNMar 31, 2026 · source ↗$5MHRZNMar 31, 2026 · source ↗$5.5MHRZNMar 31, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation